Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nonoxynol-9 is a nonionic surfactant and spermicide used primarily for non-hormonal contraception. It is the active ingredient in many over-the-counter spermicidal creams, gels, foams, films, suppositories, and lubricants. Nonoxynol-9 acts by disrupting the lipid membranes of sperm cells—specifically lysing the acrosomal membrane and damaging other organelles—leading to immobilization and death of sperm. This mechanism prevents fertilization during intercourse. Nonoxynol-9 has been widely used for more than 30 years as a locally acting contraceptive agent in conjunction with barrier methods such as condoms or diaphragms[1][3][5][6]. It does not elicit systemic effects when used vaginally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nonoxynol-9.